Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""RNA, Viral/blood"" wg kryterium: Temat


Tytuł :
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Autorzy :
Clemens Gutmann
Kaloyan Takov
Sean A. Burnap
Bhawana Singh
Hashim Ali
Konstantinos Theofilatos
Ella Reed
Maria Hasman
Adam Nabeebaccus
Matthew Fish
Mark JW. McPhail
Kevin O’Gallagher
Lukas E. Schmidt
Christian Cassel
Marieke Rienks
Xiaoke Yin
Georg Auzinger
Salvatore Napoli
Salma F. Mujib
Francesca Trovato
Barnaby Sanderson
Blair Merrick
Umar Niazi
Mansoor Saqi
Konstantina Dimitrakopoulou
Rafael Fernández-Leiro
Silke Braun
Romy Kronstein-Wiedemann
Katie J. Doores
Jonathan D. Edgeworth
Ajay M. Shah
Stefan R. Bornstein
Torsten Tonn
Adrian C. Hayday
Mauro Giacca
Manu Shankar-Hari
Manuel Mayr
Pokaż więcej
Temat :
General Physics and Astronomy
General Biochemistry, Genetics and Molecular Biology
General Chemistry
Article
Mass spectrometry
SARS-CoV-2
Prognostic markers
Adult
Animals
Antibodies, Neutralizing/immunology
Antigens, Neoplasm/metabolism
Biomarkers, Tumor/metabolism
C-Reactive Protein/metabolism
COVID-19/metabolism
Critical Care/statistics & numerical data
Female
HEK293 Cells
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Proteomics/methods
RNA, Viral/blood
SARS-CoV-2/genetics
Serum Amyloid P-Component/metabolism
Spike Glycoprotein, Coronavirus/immunology
Viral Load/immunology
Science
Źródło :
Nature Communications
Gutmann, C, Takov, K, Burnap, S A, Singh, B, Ali, H, Theofilatos, K, Reed, E, Hasman, M, Nabeebaccus, A, Fish, M, McPhail, M J, O'Gallagher, K, Schmidt, L E, Cassel, C, Rienks, M, Yin, X, Auzinger, G, Napoli, S, Mujib, S F, Trovato, F, Sanderson, B, Merrick, B, Niazi, U, Saqi, M, Dimitrakopoulou, K, Fernández-Leiro, R, Braun, S, Kronstein-Wiedemann, R, Doores, K J, Edgeworth, J D, Shah, A M, Bornstein, S R, Tonn, T, Hayday, A C, Giacca, M, Shankar-Hari, M & Mayr, M 2021, ' SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care ', Nature Communications, vol. 12, no. 1, 3406, pp. 3406 . https://doi.org/10.1038/s41467-021-23494-1
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b54981bd87b0451c4c66e6cc9dea4d
http://www.nature.com/articles/s41467-021-23494-1.pdf
Tytuł :
Screening of hepatitis E in patients presenting for acute neurological disorders
Autorzy :
Sébastien Lhomme
Olivier Epaulard
Laurence Bouillet
Jean-Luc Bosson
B. Colombe
Isabelle Boccon-Gibod
Emeline Lagrange
Vincent Leroy
M. Lugosi
A. Bosseray
Roselyne Collomb-Muret
Alban Deroux
Antoine Vilotitch
Julien Lupo
Aude Belbézier
Françoise Sarrot-Reynauld
Chantal Dumestre-Pérard
Carole Schwebel
Mathieu Vaillant
Sylvie Larrat
Perrine Dumanoir
Patrice Morand
Claire Wintenberger
Maxime Maignan
Damien Viglino
Lorella Minotti
Pokaż więcej
Temat :
Hepatitis E
Neurological disorder
Acute hepatitis
Hepatitis
MESH: Acute Disease / epidemiology
Adult
Aged
Aged, 80 and over
Brachial Plexus Neuritis / epidemiology
Female
France / epidemiology
Guillain-Barre Syndrome / epidemiology
Hepatitis Antibodies / blood
Hepatitis E / blood
Hepatitis E / diagnosis
Hepatitis E / epidemiology
Hepatitis E / immunology
Hepatitis E virus / immunology
Humans Immunoglobulin M / blood
Male
Middle Aged
Nervous System Diseases / epidemiology
Nervous System Diseases / immunology
Prospective Studies
RNA, Viral / blood
Reverse Transcriptase Polymerase Chain Reaction
Seroepidemiologic Studies
Transaminases / blood
Young Adult
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Infectious Diseases
Public Health, Environmental and Occupational Health
General Medicine
medicine.disease
medicine
Serology
business.industry
business
Internal medicine
medicine.medical_specialty
Elevated transaminases
Seroprevalence
Population
education.field_of_study
education
Hepatitis E virus
medicine.disease_cause
lcsh:Infectious and parasitic diseases
lcsh:RC109-216
lcsh:Public aspects of medicine
lcsh:RA1-1270
Źródło :
Journal of Infection and Public Health
Journal of Infection and Public Health, Elsevier, 2020, 13 (7), pp.1047-1050. ⟨10.1016/j.jiph.2019.12.012⟩
Journal of Infection and Public Health, Vol 13, Iss 7, Pp 1047-1050 (2020)
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aecd1462e1e21963b033ec84dfdb4b95
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03222802
Tytuł :
Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana
Autorzy :
Hatem Kallel
Anne Lavergne
Séverine Matheus
Claire Mayence
Benoit de Thoisy
Vincent Lacoste
Damien Donato
Stéphanie Houcke
Bhety Labeau
Didier Hommel
David Moua
Laetitia Bremand
Alexandre Roux
Dominique Rousset
Pokaż więcej
Temat :
hantavirus
hantavirus pulmonary syndrome
Maripa virus
French Guiana
antibody response
arboviruses
lcsh:Medicine
lcsh:R
lcsh:Infectious and parasitic diseases
lcsh:RC109-216
Infectious Diseases
Microbiology (medical)
Epidemiology
Virus
Hantavirus
Viral load
Viral rna
Virology
Antibody response
Disease course
Hantavirus pulmonary syndrome
RNA
Medicine
business.industry
business
viruses
MESH: Adult
MESH: Aged
MESH: Diagnosis, Differential
MESH: French Guiana
MESH: Hantavirus / immunology
MESH: Hantavirus / isolation & purification
MESH: Hantavirus Pulmonary Syndrome / diagnosis
MESH: Hantavirus Pulmonary Syndrome / mortality
MESH: Hantavirus Pulmonary Syndrome / virology
MESH: Humans
MESH: Male
MESH: Middle Aged
MESH: RNA, Viral / blood
MESH: Viral Load
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Dispatch
Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana
MESH: Hantavirus/immunology
MESH: Hantavirus/isolation & purification
MESH: Hantavirus Pulmonary Syndrome/diagnosis
MESH: Hantavirus Pulmonary Syndrome/mortality
MESH: Hantavirus Pulmonary Syndrome/virology
MESH: RNA, Viral/blood
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]
Źródło :
Emerging Infectious Diseases, Vol 24, Iss 9, Pp 1734-1736 (2018)
Emerging Infectious Diseases
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2018, 24 (9), pp.1734-1736. ⟨10.3201/eid2409.180223⟩
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2018, 24 (9), pp.1734-1736. ⟨10.3201/EID2409.180223⟩
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f12482a66d67c6a8b6c2eba4dc8b15c4
https://wwwnc.cdc.gov/eid/article/24/9/18-0223_article
Tytuł :
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
Autorzy :
Monge, S.
Mocroft, A.
Sabin, A.
Touloumi, Giota
Sighem, A.
Abgrall, S.
Dray-Spira, R.
Spire, B.
Castagna, A.
Mussini, C.
Zangerle, Robert
Hessamfar, M.
Anderson, J.
Hamouda, O.
Ehren, K.
Obel, Niels
Kirk, O.
Antinori, A.
Girardi, E.
Saracino, A.
Calmy, A.
Wit, S.
Wittkop, Linda
Bucher, C.
Montoliu, A.
Raben, Dorthe
Prins, M.
Meyer, L.
Chene, G.
Burns, F.
Amo, J.
Judd, Ali
Warszawski, Josiane
Meyer, Laurence
Dabis, François
Krause, Murielle
Ghosn, Jade
Leport, Catherine
Reiss, Peter
Wit, Ferdinand
Bucher, Heiner
Gibb, Diana
Fätkenheuer, Gerd
Amo, Julia
Thorne, Claire
Pokaż więcej
Temat :
Pharmacology (medical)
Infectious Diseases
Health Policy
Latin Americans
Demography
Medicine
business.industry
business
Western europe
Epidemiology
medicine.medical_specialty
Institutional repository
Confidence interval
Observational study
Cart
Virological response
Immunology
combination antiretroviral therapy
HIV
immunovirological response
migrants
sex
ddc:616
Adolescent
Adult
Aged
Anti-Retroviral Agents/therapeutic use
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Cohort Studies
Europe
Female
HIV Infections/drug therapy
Humans
Male
Middle Aged
Population Groups
RNA, Viral/blood
Transients and Migrants
Treatment Outcome
Viral Load
Young Adult
Źródło :
HIV Medicine, 19(1), 42. Wiley-Blackwell
HIV medicine, 19(1), 42-48. Wiley-Blackwell
HIV Medicine, Vol. 19, No 1 (2018) pp. 42-48
Opis pliku :
image/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ebdfdad503b87df5dbad12f653ec20
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fhiv.12536
Tytuł :
Detection of dicistroviruses RNA in blood of febrile Tanzanian children
Autorzy :
Cordey, Samuel
Laubscher, Florian
Hartley, Mary-Anne
Junier, Thomas
Pérez-Rodriguez, Francisco J.
Keitel, Kristina
Vieille, Gael
Samaka, Josephine
Mlaganile, Tarsis
Kagoro, Frank
Boillat-Blanco, Noémie
Mbarack, Zainab
Docquier, Mylène
Brito, Francisco
Eibach, Daniel
May, Jürgen
Sothmann, Peter
Aldrich, Cassandra
Lusingu, John
Tapparel, Caroline
D’Acremont, Valérie
Kaiser, Laurent
Pokaż więcej
Temat :
Child
Child, Preschool
Cohort Studies
Female
Fever/blood
Fever/virology
Humans
Infant
Male
Phylogeny
Polymerase Chain Reaction
RNA, Viral/blood
Tanzania
Virus Diseases/blood
Virus Diseases/genetics
Virus Diseases/virology
Viruses/classification
Viruses/isolation & purification
Dicistrovirus
Tanzanian children
de novo analysis
sera
viremia
Immunology
Epidemiology
Microbiology
Drug Discovery
Parasitology
Virology
Infectious Diseases
General Medicine
ddc:616
ddc:590
ddc:576.5
Preschool
Fever/blood/virology
RNA
Viral/blood
Virus Diseases/blood/genetics/virology
Viruses/classification/isolation & purification
Article
Plasma samples
Viral load
Pathogen
Phylogenetics
Capsid
Polymerase chain reaction
law.invention
law
Viremia
medicine.disease
medicine
Biology
Źródło :
Emerging microbes & infections, vol. 8, no. 1, pp. 613-623
Emerging Microbes & Infections
Emerging Microbes & Infections, Vol. 8, No 1 (2019) pp. 613-623
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a253c496fe3615282e921b144b85c9
https://serval.unil.ch/resource/serval:BIB_EC0E536871A0.P001/REF.pdf
Tytuł :
Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1
Autorzy :
Kouanfack, C.
Mpoudi-Etame, Mireille
Omgba Bassega, P.
Eymard-Duvernay, S.
Leroy, S.
Boyer, S.
Peeters, M.
Calmy, A.
Delaporte, E.
Pokaż więcej
Temat :
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
ddc:616
Adult
Benzoxazines/administration & dosage/adverse effects
Drug Therapy, Combination
Female
HIV Infections/drug therapy
HIV Integrase Inhibitors/adverse effects/therapeutic use
HIV-1/genetics/isolation & purification
Heterocyclic Compounds, 3-Ring/administration & dosage/adverse effects
Humans
Lamivudine/administration & dosage
Male
Obesity/chemically induced
Pregnancy
RNA, Viral/blood
Tenofovir/administration & dosage
Viral Load/drug effects
Weight Gain/drug effects
General Medicine
Dolutegravir
chemistry.chemical_compound
chemistry
Internal medicine
medicine.medical_specialty
medicine
Regimen
Acquired immunodeficiency syndrome (AIDS)
medicine.disease
Viral load
Lamivudine
medicine.drug
Clinical endpoint
business.industry
business
Confidence interval
Efavirenz
Źródło :
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (9), pp.816-826. ⟨10.1056/NEJMoa1904340⟩
New England Journal of Medicine, Vol. 381, No 9 (2019) pp. 816-826
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f97a7b4605ac78a60ffa320ad36429
https://hal.archives-ouvertes.fr/hal-02479607
Tytuł :
Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc
Autorzy :
Susan J. Little
Antoine Chaillon
Josué Pérez-Santiago
Sanjay Mehta
Sara Gianella
Steven M. Lada
Joel O. Wertheim
Caroline C. Ignacio
Douglas D. Richman
Davey M. Smith
Parris Jordan
Maile Y. Karris
Pokaż więcej
Temat :
Genetic Diversity and Evolution
Virology
Insect Science
Immunology
Microbiology
Viral evolution
Interquartile range
Maraviroc
chemistry.chemical_compound
chemistry
Viremia
medicine.disease
medicine
Biology
Viral replication
Entry inhibitor
medicine.drug
Deep sequencing
Viral load
Humans
HIV-1
HIV Infections
Cyclohexanes
Triazoles
DNA, Viral
RNA, Viral
Antiretroviral Therapy, Highly Active
Viral Load
Bayes Theorem
Double-Blind Method
Virus Replication
Adult
California
Female
Male
Young Adult
CCR5 Receptor Antagonists
ART intensification
HIV
evolution
reservoir
Adult Antiretroviral Therapy, Highly Active Bayes Theorem CCR5 Receptor Antagonists/*therapeutic use California Cyclohexanes/*therapeutic use DNA, Viral/blood Double-Blind Method Female HIV Infections/*drug therapy/virology HIV-1/genetics/physiology Humans Male Maraviroc RNA, Viral/blood Triazoles/*therapeutic use Viral Load Viremia/*drug therapy Virus Replication/*drug effects Young Adult *ART intensification *Hiv *evolution *maraviroc *reservoir
Biological Sciences
Agricultural and Veterinary Sciences
Medical and Health Sciences
DNA
Viral
RNA
Antiretroviral Therapy
Highly Active
Clinical Research
Infectious Diseases
Clinical Trials and Supportive Activities
HIV/AIDS
6.1 Pharmaceuticals
Infection
Adult Antiretroviral Therapy
Highly Active Bayes Theorem CCR5 Receptor Antagonists/*therapeutic use California Cyclohexanes/*therapeutic use DNA
Viral/blood Double-Blind Method Female HIV Infections/*drug therapy/virology HIV-1/genetics/physiology Humans Male Maraviroc RNA
Viral/blood Triazoles/*therapeutic use Viral Load Viremia/*drug therapy Virus Replication/*drug effects Young Adult *ART intensification *Hiv *evolution *maraviroc *reservoir
Źródło :
Chaillon, Antoine; Gianella, Sara; Lada, Steven M; Perez-Santiago, Josué; Jordan, Parris; Ignacio, Caroline; et al.(2018). Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.. Journal of virology, 92(3). doi: 10.1128/JVI.01589-17. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2dz5q4q8
Journal of virology, vol 92, iss 3
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5db9c6ca94addc5ddb77c1d14d6fc0
https://europepmc.org/articles/PMC5774877/
Tytuł :
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Autorzy :
Venter, Willem D.F.
Moorhouse, Michelle
Sokhela, Simiso
Fairlie, Lee
Mashabane, Nkuli
Masenya, Masebole
Serenata, Celicia
Akpomiemie, Godspower
Qavi, Ambar
Chandiwana, Nomathemba
Norris, Shane
Chersich, Matthew
Clayden, Polly
Abrams, Elaine
Arulappan, Natasha
Vos, Alinda
McCann, Kaitlyn
Simmons, Bryony
Hill, Andrew
Pokaż więcej
Temat :
Adenine/administration & dosage
Adolescent
Adult
Anti-Retroviral Agents/administration & dosage
Bone Density/drug effects
CD4 Lymphocyte Count
Drug Therapy
Combination
Female
HIV Infections/drug therapy
HIV Integrase Inhibitors/administration & dosage
HIV-1/genetics
Heterocyclic Compounds
3-Ring/administration & dosage
Humans
Intention to Treat Analysis
Male
Middle Aged
Phosphorous Acids/administration & dosage
Pregnancy
Pregnancy Complications
Infectious/drug therapy
Prodrugs/administration & dosage
RNA
Viral/blood
Uracil/administration & dosage
Viral Load
Young Adult
Medicine(all)
Research Support
Non-U.S. Gov't
Randomized Controlled Trial
Clinical Trial
Phase III
Journal Article
Comparative Study
General Medicine
Prodrug
Dolutegravir
chemistry.chemical_compound
chemistry
Efavirenz
Antiretroviral therapy
Medicine
business.industry
business
Tenofovir
medicine.drug
Human immunodeficiency virus (HIV)
medicine.disease_cause
Pharmacotherapy
Viral load
Virology
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
ANTIRETROVIRAL THERAPY
INFECTION
RECOMMENDATIONS
GUIDELINES
EFAVIRENZ
PROGRAMS
EFFICACY
OBESITY
ADULTS
RISKS
Adenine
Anti-Retroviral Agents
Bone Density
Drug Therapy, Combination
HIV Infections
HIV Integrase Inhibitors
HIV-1
Heterocyclic Compounds, 3-Ring
Phosphorous Acids
Pregnancy Complications, Infectious
Prodrugs
RNA, Viral
Uracil
11 Medical and Health Sciences
Heterocyclic Compounds, 3-Ring/administration & dosage
Pregnancy Complications, Infectious/drug therapy
RNA, Viral/blood
Research Support, Non-U.S. Gov't
Clinical Trial, Phase III
Źródło :
The New England journal of medicine, 381(9), 803. Massachussetts Medical Society
Opis pliku :
image/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eedd168d3a983a91c704e487bf7d8da1
Tytuł :
Plasma HIV-1 Tropism and the Risk of Short- Term Clinical Progression to AIDS or Death
Autorzy :
Dalibor Sedláček
Maria Casadellà Fontdevila
Gitte Kronborg
Marc Noguera I Julian
Kai Zilmer
Adriano Lazzarin
Andrew W Phillips
Roger Paredes
Bonaventura Clotet
Jens D. Lundgren
Marcus Bickel
Alessandro Cozzi-Lepri
Pokaż więcej
Temat :
Acquired Immunodeficiency Syndrome/blood
Adult
Anti-HIV Agents/therapeutic use
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes/virology
Disease Progression
Female
HIV-1/genetics
Humans
Male
Middle Aged
RNA, Viral/blood
Viral Load/genetics
Viral Tropism/genetics
Journal Article
Research Support, Non-U.S. Gov't
Multidisciplinary
HIV tropism
Risk factor
Acquired immunodeficiency syndrome (AIDS)
medicine.disease
medicine
Tropism
Internal medicine
medicine.medical_specialty
Virology
Tissue tropism
business.industry
business
Population
education.field_of_study
education
Viral load
Human immunodeficiency virus (HIV)
medicine.disease_cause
Research Article
Biology and Life Sciences
Microbiology
Viral Tropism
Medical Microbiology
Microbial Pathogens
Viral Pathogens
Immunodeficiency Viruses
HIV
Medicine and Health Sciences
Pathology and Laboratory Medicine
Pathogens
Organisms
Viruses
RNA viruses
Retroviruses
Lentivirus
Infectious Diseases
Viral Diseases
AIDS
Viral Transmission and Infection
Viral Load
HIV-1
Diagnostic medicine
HIV diagnosis and management
Immunology
Vaccination and Immunization
Antiviral Therapy
Antiretroviral Therapy
Public and Occupational Health
Preventive Medicine
Epidemiology
HIV epidemiology
lcsh:Medicine
lcsh:R
lcsh:Science
lcsh:Q
ddc:610
Sida -- Tractament
VIH (Virus)
Źródło :
Casadellà, M, Cozzi-Lepri, A, Phillips, A, Noguera-Julian, M, Bickel, M, Sedlacek, D, Zilmer, K, Clotet, B, Lundgren, J D, Paredes, R & EuroSIDA in EuroCoord 2017, ' Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death ', PloS one, vol. 12, no. 1, e0166613 . https://doi.org/10.1371/journal.pone.0166613
PLoS ONE
PLoS ONE, Vol 12, Iss 1, p e0166613 (2017)
Opis pliku :
application/pdf; application/octet-stream
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024990dcfd0b8340b1d78d25e55a519f
http://ddd.uab.cat/record/196308
Tytuł :
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Autorzy :
Céline Dorival
Matthew L. Albert
Jean-Pierre Bronowicki
Armanda Casrouge
Stanislas Pol
Hélène Fontaine
Christophe Hézode
Arnaud Fontanet
Vincent Mallet
Fabrice Carrat
Estelle Mottez
Yoann Barthe
Ioannis Theodorou
S. Lagaye
Etienne Gayat
Laurent Abel
Philippe Sultanik
Pokaż więcej
Temat :
HCV protease inhibitor
apolipoprotein H
biomarker
chronic hepatitis C
virological response
MESH: Aged
MESH: Antiviral Agents/therapeutic use
MESH: Protease Inhibitors/therapeutic use
MESH: RNA, Viral/blood
MESH: Hepacivirus/growth & development
MESH: ROC Curve
MESH: Recombinant Proteins/therapeutic use
MESH: Ribavirin/therapeutic use
MESH: Biomarkers/blood
MESH: Time Factors
MESH: Treatment Outcome
MESH: Viral Load
MESH: Molecular Targeted Therapy
MESH: Viral Nonstructural Proteins/antagonists & inhibitors
MESH: Viral Nonstructural Proteins/metabolism
MESH: Virus Replication/drug effects
MESH: Hepatitis C, Chronic/blood
MESH: beta 2-Glycoprotein I/blood
MESH: Drug Therapy, Combination
MESH: Female
MESH: France
MESH: Hepacivirus/drug effects
MESH: Hepacivirus/enzymology
MESH: Oligopeptides/therapeutic use
MESH: Hepacivirus/genetics
MESH: Hepatitis C, Chronic/diagnosis
MESH: Hepatitis C, Chronic/drug therapy
MESH: Humans
MESH: Interferon-alpha/therapeutic use
MESH: Male
MESH: Middle Aged
MESH: Area Under Curve
MESH: Polyethylene Glycols/therapeutic use
MESH: Predictive Value of Tests
MESH: Proline/analogs & derivatives
MESH: Proline/therapeutic use
MESH: Prospective Studies
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH : Aged
MESH : Antiviral Agents/therapeutic use
MESH : Molecular Targeted Therapy
MESH : Oligopeptides/therapeutic use
MESH : Area Under Curve
MESH : Polyethylene Glycols/therapeutic use
MESH : Predictive Value of Tests
MESH : Proline/analogs & derivatives
MESH : Proline/therapeutic use
MESH : Prospective Studies
MESH : Protease Inhibitors/therapeutic use
MESH : RNA, Viral/blood
MESH : Hepacivirus/growth & development
MESH : ROC Curve
MESH : Recombinant Proteins/therapeutic use
MESH : Ribavirin/therapeutic use
MESH : Biomarkers/blood
MESH : Time Factors
MESH : Treatment Outcome
MESH : Viral Load
MESH : Viral Nonstructural Proteins/antagonists & inhibitors
MESH : Viral Nonstructural Proteins/metabolism
MESH : Virus Replication/drug effects
MESH : Hepatitis C, Chronic/blood
MESH : beta 2-Glycoprotein I/blood
MESH : Drug Therapy, Combination
MESH : Female
MESH : France
MESH : Hepacivirus/drug effects
MESH : Hepacivirus/enzymology
MESH : Hepacivirus/genetics
MESH : Hepatitis C, Chronic/diagnosis
MESH : Hepatitis C, Chronic/drug therapy
MESH : Humans
MESH : Interferon-alpha/therapeutic use
MESH : Male
MESH : Middle Aged
[ SDV.IMM ] Life Sciences [q-bio]/Immunology
Hepatology
Immunology
Blood proteins
Telaprevir
medicine.drug
medicine
NS3
Ribavirin
chemistry.chemical_compound
chemistry
Biology
Boceprevir
Apolipoprotein H
Surrogate endpoint
Biomarker (medicine)
virus diseases
digestive system diseases
Źródło :
Liver International
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. 〈10.1111/liv.12759〉
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90633f842d8de6ea3f7f4df0ad3c882d
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380846
Tytuł :
Associations between HIV-RNA-based indicators and virological and clinical outcomes
Autorzy :
Laut, Kamilla G.
Shepherd, Leah C.
Pedersen, Court
Rockstroh, Jürgen K.
Sambatakou, Helen
Paduta, Dimitry
Matulionyte, Raimonda
Smiatacz, Tomasz
Mulcahy, Fiona
Lundgren, Jens D.
Mocroft, Amanda
Kirk, Ole
Gatell, J.
Gazzard, B.
Horban, A.
Karpov, I.
Ledergerber, B.
Losso, M.
Monforte, A. D arminio
Rakhmanova, A.
Ristola, M.
Phillips, A.
Reiss, P.
Lundgren, J.
Rockstroh, J.
De Wit, S.
Kirk, O.
Mocroft, A.
Grarup, J.
Cozzi-Lepri, A.
Thiebaut, R.
Burger, D.
Paredes, R.
Peters, L.
Pokaż więcej
Temat :
AIDS
benchmarking
HIV
outcome assessment (healthcare)
quality indicators
viral load
Health Status Indicators
Humans
Middle Aged
Male
Treatment Outcome
HIV Infections/diagnosis
Drug Monitoring/methods
RNA, Viral/blood
Survival Analysis
Adult
Female
Cohort Studies
Infectious Diseases
Immunology
Immunology and Allergy
Viral load
Incidence (epidemiology)
Internal medicine
medicine.medical_specialty
medicine
Poisson regression
symbols.namesake
symbols
Observational study
Cohort study
Multivariate statistics
Acquired immunodeficiency syndrome (AIDS)
medicine.disease
business.industry
business
Survival analysis
Źródło :
Laut, K G, Shepherd, L C, Pedersen, C, Rockstroh, J K, Sambatakou, H, Paduta, D, Matulionyte, R, Smiatacz, T, Mulcahy, F, Lundgren, J D, Mocroft, A, Kirk, O, Gatell, J, Gazzard, B, Horban, A, Karpov, I, Ledergerber, B, Losso, M, Monforte, A D A, Rakhmanova, A, Ristola, M, Phillips, A, Reiss, P, Lundgren, J, Rockstroh, J, De Wit, S, Rockstroh, J, De Wit, S, Kirk, O, Mocroft, A, Grarup, J, Reiss, P, Cozzi-Lepri, A, Thiebaut, R, Rockstroh, J, Burger, D, Paredes, R & Peters, L 2016, ' Associations between HIV-RNA-based indicators and virological and clinical outcomes ', AIDS, vol. 30, no. 12, pp. 1961-1972 . https://doi.org/10.1097/QAD.0000000000001144
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d19c58500bc0143d227ebdd90f9246d
http://www.scopus.com/inward/record.url?scp=84965017129&partnerID=8YFLogxK
Tytuł :
(1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study
Autorzy :
Hoenigl, Martin
de Oliveira, Michelli Faria
Pérez-Santiago, Josué
Zhang, Yonglong
Morris, Sheldon
McCutchan, Allen J
Finkelman, Malcolm
Marcotte, Thomas D
Ellis, Ronald J
Gianella, Sara
Pokaż więcej
Temat :
Humans
HIV
HIV Infections
beta-Glucans
RNA, Viral
Interleukin-8
Anti-HIV Agents
CD4 Lymphocyte Count
Severity of Illness Index
Retrospective Studies
Cross-Sectional Studies
Cognition Disorders
Neuropsychological Tests
Bacterial Translocation
Adult
Aged
Middle Aged
Female
Male
Biomarkers
Lipopolysaccharide Receptors
Adult Aged Anti-HIV Agents/therapeutic use Bacterial Translocation Biomarkers/blood/cerebrospinal fluid CD4 Lymphocyte Count Cognition Disorders/*blood/cerebrospinal fluid Cross-Sectional Studies Female *Hiv HIV Infections/*blood/cerebrospinal fluid/drug therapy Humans Interleukin-8/blood/cerebrospinal fluid Lipopolysaccharide Receptors/blood/cerebrospinal fluid Male Middle Aged Neuropsychological Tests RNA, Viral/*blood Retrospective Studies Severity of Illness Index beta-Glucans/*blood/*cerebrospinal fluid
Clinical Sciences
Arthritis & Rheumatology
RNA
Viral
Mental Health
Clinical Research
Acquired Cognitive Impairment
Infectious Diseases
Neurosciences
HIV/AIDS
Brain Disorders
2.1 Biological and endogenous factors
6.1 Pharmaceuticals
Infection
Adult Aged Anti-HIV Agents/therapeutic use Bacterial Translocation Biomarkers/blood/cerebrospinal fluid CD4 Lymphocyte Count Cognition Disorders/*blood/cerebrospinal fluid Cross-Sectional Studies Female *Hiv HIV Infections/*blood/cerebrospinal fluid/drug therapy Humans Interleukin-8/blood/cerebrospinal fluid Lipopolysaccharide Receptors/blood/cerebrospinal fluid Male Middle Aged Neuropsychological Tests RNA
Viral/*blood Retrospective Studies Severity of Illness Index beta-Glucans/*blood/*cerebrospinal fluid
Źródło :
Hoenigl, Martin; de Oliveira, Michelli Faria; Pérez-Santiago, Josué; Zhang, Yonglong; Morris, Sheldon; McCutchan, Allen J; et al.(2016). (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.. Medicine, 95(11), e3162. doi: 10.1097/MD.0000000000003162. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/5h61w448
Medicine, vol 95, iss 11
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bec041a8c1671d69d15e18f481ba505a
http://www.escholarship.org/uc/item/5h61w448
Tytuł :
Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project
Autorzy :
Arjan E. R. Bos
Sarah E. Stutterheim
Mireille E. G. Wolfers
Sabrina K. Been
David A. M. C. van de Vijver
Inês Brito
Annelies Verbon
Katalin Pogány
Pythia T. Nieuwkerk
Pokaż więcej
Temat :
lcsh:Medicine
lcsh:R
lcsh:Science
lcsh:Q
Adult
Anti-HIV Agents/therapeutic use
Antiretroviral Therapy, Highly Active
Cross-Sectional Studies
Databases, Factual
Emigrants and Immigrants/psychology
Female
HIV/genetics
HIV Infections/drug therapy
Humans
Interviews as Topic
Logistic Models
Male
Medication Adherence/statistics & numerical data
Middle Aged
Netherlands
Odds Ratio
RNA, Viral/blood
Risk Factors
Self Efficacy
Self Report
Social Support
Young Adult
ACTIVE ANTIRETROVIRAL THERAPY
SELF-REPORTED ADHERENCE
HIV-1-INFECTED PATIENTS
VIROLOGICAL RESPONSE
CLINICAL-TRIALS
COHORT
PREDICTORS
OUTCOMES
AFRICAN
PEOPLE
Research Article
Biology and Life Sciences
Microbiology
Medical Microbiology
Microbial Pathogens
Viral Pathogens
Immunodeficiency Viruses
HIV
Medicine and Health Sciences
Pathology and Laboratory Medicine
Pathogens
Organisms
Viruses
RNA viruses
Retroviruses
Lentivirus
Health Care
Quality of Life
Social Sciences
Sociology
Education
Schools
Educational Attainment
Psychological and Psychosocial Issues
People and Places
Geographical Locations
Europe
Africa
Immunology
Vaccination and Immunization
Antiviral Therapy
Antiretroviral Therapy
Public and Occupational Health
Preventive Medicine
Multidisciplinary
Family medicine
medicine.medical_specialty
medicine
Outpatient clinic
Odds ratio
Quality of life
business.industry
business
Social support
Self-efficacy
Psychosocial
Cross-sectional study
Cart
Gerontology
Źródło :
PLoS ONE, Vol 11, Iss 10, p e0162800 (2016)
PLOS ONE, 11(10):e0162800. Public Library of Science
PLoS ONE, 11(10). Public Library of Science
Been, S K, van de Vijver, D A M C, Nieuwkerk, P T, Brito, I, Stutterheim, S E, Bos, A E R, Wolfers, M E G, Pogany, K & Verbon, A 2016, ' Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands : Results from the ROtterdam ADherence (ROAD) Project ', PLOS ONE, vol. 11, no. 10, e0162800 . https://doi.org/10.1371/journal.pone.0162800
PLoS ONE
PLoS ONE, 11(10)
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87e312fc0bd9e836bba26f0dc434755
Tytuł :
Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART
Autorzy :
Steven Paul Woods
Igor Grant
Josué Pérez-Santiago
Milenka V. Vargas
Michelli F. Oliveira
Scott Letendre
Davey M. Smith
Sara Gianella
Ben Murrell
Ronald J. Ellis
Pokaż więcej
Temat :
Article
Multidisciplinary
Young adult
Cerebrospinal fluid
Hiv infected
Medicine
business.industry
business
Pathogenesis
Correlation and dependence
Executive functions
Immunology
Neurocognitive
Inflammation
medicine.symptom
Leukocytes, Mononuclear
Monocytes
Humans
HIV-1
HIV Infections
RNA, Viral
Cytokines
Anti-HIV Agents
Cognition Disorders
Age Factors
Adult
Aged
Middle Aged
Female
Male
Chemokine CCL2
Young Adult
Executive Function
Adult Age Factors Aged Anti-HIV Agents/*therapeutic use Chemokine CCL2/blood/cerebrospinal fluid Cognition Disorders/*pathology Cytokines/blood/cerebrospinal fluid Executive Function/physiology Female HIV Infections/*drug therapy/virology HIV-1/*genetics Humans Leukocytes, Mononuclear/virology Male Middle Aged Monocytes/cytology/metabolism RNA, Viral/*blood/cerebrospinal fluid Young Adult
Źródło :
Scientific Reports
de Oliveira, Michelli Faria; Murrell, Ben; Pérez-Santiago, Josué; Vargas, Milenka; Ellis, Ronald J; Letendre, Scott; et al.(2015). Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART.. Scientific reports, 5(1), 17094. doi: 10.1038/srep17094. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/2t51n55x
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24b13cdb8fd82e5ab70aeb1364fe5e7
http://europepmc.org/articles/PMC4658529

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies